DRI Healthcare delays London flotation, blaming Covid-19 meltdown

DRI_Covid_PA_575_375
By Aidan Gregory
28 Feb 2020

DRI Healthcare, the Canadian investment fund focused on pharmaceutical royalties, has postponed its $350m IPO on the London Stock Exchange, blaming the global equity market selloff caused by the spread of the Covid-19 virus.

“The IPO has been very well received by a large number of institutional investors and discretionary wealth managers,” said DRI Healthcare, in a regulatory filing on Friday. “However, in light of current volatile market conditions, the board believes it is investors' interests to extend the timetable. ...

Please take a trial or subscribe to access this content.

Contact our subscriptions team to discuss your access: subs@globalcapital.com

Or sign up for a trial to gain full access to the entire site for a limited period.

Free Trial

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.